Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Pancreatic Neoplasms 2Obesity 2Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Treatment Adherence and Compliance 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Smoking 1Sarcoma 1Risk Reduction Behavior 1Rectal Neoplasms 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Prosthesis-Related Infections 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Polycystic Ovary Syndrome 1Overweight 1Osteosarcoma 1Orgasm 1Obesity, Morbid 1Noncommunicable Diseases 1Neuroendocrine Tumors 1

Interventions

Vitamin D 1Synbiotics 1Prebiotics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER_GOV × Chemotherapy-Related Cognitive Impairment × Clear all
NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Instituto Jalisciense de Cancerologia

Phase NA Enrolling by invitation
80 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡